Breast cancer Posts on Medivizor
Navigation Menu

Breast cancer Posts on Medivizor

Chemotherapy in patients with hormone receptor positive, node positive invasive breast cancer

Posted by on Dec 30, 2019 in Breast cancer | 0 comments

In a nutshell This study wanted to find out how well chemotherapy for invasive breast cancer works, especially in those over 70 years old. The study found that most patients benefit from chemotherapy, however, those aged over 70 benefited less of this treatment than those aged under 70. Some background Most types of breast cancer have guidelines with...

Read More

Adding targeted therapy to chemotherapy and surgery in patients with breast cancer

Posted by on Dec 30, 2019 in Breast cancer | 0 comments

In a nutshell This study wanted to find out if adding targeted therapies to chemotherapy before surgery improved outcomes in patients with breast cancer. The study found that patients responded to treatment better when a targeted therapy was added to chemotherapy and surgery treatment. Some background There are multiple ways to treat breast...

Read More

Safety and effectiveness of pembrolizumab and radiotherapy in patients with metastatic triple-negative breast cancer

Posted by on Dec 17, 2019 in Breast cancer | 0 comments

In a nutshell This study aimed to investigate the effectiveness and safety of pembrolizumab and radiotherapy in patients with metastatic triple-negative breast cancer.  This study concluded that this combination was found to be safe and promising in these patients.  Some background Pembrolizumab (Keytruda) is a targeted...

Read More

Palbociclib and exemestane versus capecitabine in premenopausal women with hormone receptor-positive metastatic breast cancer

Posted by on Dec 7, 2019 in Breast cancer | 0 comments

In a nutshell This study aimed to compare the safety and effectiveness of palbociclib and endocrine therapy to capecitabine chemotherapy in premenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer.  This study concluded that palbociclib and endocrine therapy is more effective than...

Read More

My Oncologist Doesn’t Believe Food Is Necessary

My Oncologist Doesn’t Believe Food Is Necessary

Posted by on Dec 3, 2019 in Blog, Breast cancer, Colorectal cancer, Leukemia, Lung cancer, Lymphoma, Melanoma, Multiple Myeloma, Non-Hodgkin lymphoma, Prostate cancer | 3 comments

By Steve Gillman What my cancer taught me about medical “evidence” and how much is enough I exaggerate. My oncologist probably does believe humans need food, but I suspect the belief makes him uncomfortable, since no double-blind studies have been done to prove it. Like many doctors, his general approach to treatment is that if something hasn’t been...

Read More

The effect of fertility preservation on disease free survival in patients with invasive breast cancer

Posted by on Nov 29, 2019 in Breast cancer | 0 comments

In a nutshell This study aimed to investigate if fertility preservation in patients with invasive breast cancer would affect disease-free survival. This study concluded that fertility preservation appears unlikely to affect disease-free survival in these patients.   Some background Fertility preservation (FP) is the process of saving or...

Read More

Trastuzumab emtansine with or without pertuzumab versus trastuzumab with taxane for HER2+ advanced breast cancer

Posted by on Nov 2, 2019 in Breast cancer | 0 comments

In a nutshell This study wanted to find out which treatment resulted in better overall survival for patients with HER2+ breast cancer; trastuzumab emtansine (Kadcycla) with or without pertuzumab (Perjeta), or trastuzumab (Herceptin) plus a taxane. The study found that the overall survival was similar across...

Read More

Looking for patients with advanced triple negative breast cancer to test an experimental drug with three functions

Posted by on Oct 31, 2019 in Breast cancer | 0 comments

In a nutshell This trial is examining the safety and effectiveness of experimental drug mRNA-2752 in patients with advanced triple-negative breast cancer. The main outcome of the trial will be the number of side effects experienced by patients and response to treatment. This trial is recruiting in the United States and Israel. The details...

Read More

Searching for patients with early breast cancer to trial a partial-radiation treatment

Posted by on Oct 24, 2019 in Breast cancer | 0 comments

In a nutshell This trial aims to find out what dose of radiation therapy is effective in the shortest time period for women with newly diagnosed breast cancer, or ductal carcinoma in-situ (DCIS). The main outcome that will be measured is if patients experience any side effects. The study is taking place in New Jersey and New York, the United States. The...

Read More